MedDataX Logo

Hemodynamics During the Soccer Championship 2012

NCT ID: NCT01617863

Last Updated: 2012-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

180 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-06-30

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine in soccer fans whether and to which extend positive or negative emotions during the European soccer Championship affects Central Hemodynamics, Arterial Stiffness, Heartrate and Endothelial Dysfunktion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severe Cardiomyopathy Angina, Unstable Myocardial Infarction Angina, Stable

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Best fit:

* cardiomyopathy "severe myocardial disease leading to heart failure"
* Angina, stable for at least 7 days
* Myocardial infarction during 4 weeks before inclusion, actually stable condition
* Angina, Stable, CCS II-IV

Exclusion Criteria

* not interested in soccer championship
* age \<18y
* dementia
* atrial tachycardia
* drug/alcohol abuse
* chronic kidney disease, stage 5
* pulmonary/tricuspid valve insufficiency/stenoses
* non compliant
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitätsklinikum Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany

UNKNOWN

Sponsor Role collaborator

Universitätsklinikum Erlangen, Erlangen, Bayern, Germany

UNKNOWN

Sponsor Role collaborator

Universitätsklinikum Eppendedorf, Hamburg, Germany

UNKNOWN

Sponsor Role collaborator

UKSH Campus Kiel, Kiel, Germany

UNKNOWN

Sponsor Role collaborator

University Hospital Schleswig-Holstein

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

PD. Dr. med Michael Reppel

PD Dr. med Reppel

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Reppel, PD. Dr. med

Role: STUDY_DIRECTOR

UKSH- Lübeck Medizinische Klinik 2

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitätsklinikum Erlangen

Erlangen, Bavaria, Germany

Site Status

Universitätsklinikum Eppendorf

Hamburg, City state of Hamburg, Germany

Site Status

Universitätsklinikum Greifswald

Greifswald, Mecklenburg-Vorpommern, Germany

Site Status

UKSH-Lübeck

Lübeck, Schleswig-Holstein, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HL-Med2-EM-2012

Identifier Type: -

Identifier Source: org_study_id